Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes.

Author: CarneyO, FahertyA, FrerisM, MindelA, PatouG, WilliamsP

Paper Details 
Original Abstract of the Article :
131 patients with frequently recurring genital herpes were treated for 1 year with reducing doses of oral acyclovir. The time to first recurrence in patients who commenced therapy on 400 mg twice a day was statistically significantly shorter than those on 200 mg four times a day (p less than 0.02) a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/s0140-6736(88)91725-4

データ提供:米国国立医学図書館(NLM)

Long-Term Acyclovir Therapy for Recurrent Genital Herpes: A Quest for Control

Recurrent genital herpes is a common and challenging condition, like a recurring sandstorm that disrupts the peace of a desert oasis. This study investigates the safety and effectiveness of long-term suppressive acyclovir therapy for patients with frequent genital herpes recurrences. The researchers explored the optimal dosage and treatment duration for acyclovir, aiming to identify a safe and effective strategy for managing this condition.

Acyclovir: A Beacon of Hope in the Desert of Herpes

This study offers valuable insights into the management of recurrent genital herpes. The researchers found that long-term suppressive acyclovir therapy was effective in reducing the frequency of recurrences and was generally well-tolerated by patients. This finding is encouraging for individuals seeking relief from the recurrent symptoms of genital herpes. It's like discovering a new source of water in the desert, providing a measure of control and stability amidst the challenges.

Navigating the Desert of Herpes: Finding the Right Approach

It’s crucial to work closely with a healthcare professional to determine the best treatment strategy for recurrent genital herpes. The choice of therapy should be individualized, considering the patient's specific needs and response to medication. It's like choosing the right camel for a desert journey, ensuring that your mode of transportation is well-suited to the challenges ahead. This research provides valuable insights into the management of recurrent genital herpes, guiding clinicians and patients toward more informed treatment decisions.

Dr.Camel's Conclusion

This study underscores the potential benefits of long-term acyclovir therapy for recurrent genital herpes. It's a reminder that with the right approach, we can find ways to manage even the most challenging conditions, just as a wise camel navigates the vast and unforgiving desert.
Date :
  1. Date Completed 1988-05-26
  2. Date Revised 2021-12-03
Further Info :

Pubmed ID

2895840

DOI: Digital Object Identifier

10.1016/s0140-6736(88)91725-4

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.